Cancer drug resistance: a new perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer drug resistance: a new perspective

Published:2018-03-19 Issue:1 Volume:1 Page:1-5
ISSN:
Container-title:Cancer Drug Resistance
language:
Short-container-title:CDR

Author:

Peters Godefridus J.

Publisher

OAE Publishing Inc.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smart perhydroxycucurbit [6] uril functionalized magnetic graphene oxide for release of Naringin as an antitumor agent;Advanced Powder Technology;2023-12

2. Automatic Hemiplegia Gait Assessment for Post-Stroke by an Efficient Hybrid Attention-Based GhostNet;2023 International Joint Conference on Neural Networks (IJCNN);2023-06-18

3. The Influence of Mitochondrial Energy and 1C Metabolism on the Efficacy of Anticancer Drugs: Exploring Potential Mechanisms of Resistance;Current Medicinal Chemistry;2023-04

4. Synthesis, characterization, cytotoxicity evaluation and molecular docking study of new bis-chalcone, fused-pyrimidine and fused-pyrazoline derivatives;Indian Journal of Chemistry;2023-03-17

5. Finding Molecular Inhibitors of the Inflammatory Pathway in the Large Intestine Along with Molecular Dynamics with Emphasis on the Use of TCM Database;Gene, Cell and Tissue;2023-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3